These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31537337)

  • 21. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.
    Greenspon AJ; Patel JD; Lau E; Ochoa JA; Frisch DR; Ho RT; Pavri BB; Kurtz SM
    J Am Coll Cardiol; 2011 Aug; 58(10):1001-6. PubMed ID: 21867833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
    Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of delayed device re-implantation on outcomes of patients with cardiovascular implantable electronic device related infective endocarditis.
    Arshad V; Baddour LM; Lahr BD; Khalil S; Tariq W; Talha KM; Cha YM; DeSimone DC; Sohail MR
    Pacing Clin Electrophysiol; 2021 Aug; 44(8):1303-1311. PubMed ID: 34132396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of bacteremia in patients living with cardiovascular implantable electronic devices.
    DeSimone DC; Sohail MR
    Heart Rhythm; 2016 Nov; 13(11):2247-2252. PubMed ID: 27546815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.
    Han HC; Hawkins NM; Pearman CM; Birnie DH; Krahn AD
    Europace; 2021 Jun; 23(23 Suppl 4):iv3-iv10. PubMed ID: 34051086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
    Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
    Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors for cardiac implantable electronic device infection in current clinical settings in a Japanese population: A 20-year single-center observational study.
    Ishiguchi H; Ishikura M; Yoshida M; Imoto K; Sonoyama K; Kawabata T; Ishihara Y; Yoshiga Y; Shimizu A; Oda T
    J Cardiol; 2020 Jul; 76(1):115-122. PubMed ID: 32037251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
    Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
    Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for cardiac implantable electronic device infections: a nationwide Danish study.
    Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Frausing MHJP; Sandgaard NCF; Johansen JB
    Eur Heart J; 2022 Dec; 43(47):4946-4956. PubMed ID: 36263789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.
    Tarakji KG; Wilkoff BL
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):607-16. PubMed ID: 23621142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the 30-year span of noninfectious cardiovascular implantable electronic device complications in Olmsted County.
    Kowlgi GN; Vaidya V; Dai MY; Futela P; Mishra R; Hodge DO; Deshmukh AJ; Mulpuru SK; Friedman PA; Cha YM
    Heart Rhythm O2; 2024 Mar; 5(3):158-167. PubMed ID: 38560372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seasonal variations in cardiac implantable electronic device infections.
    Maille B; Koutbi L; Resseguier N; Lemoine C; Thuny F; Peyrol M; Hourdain J; Deharo JC; Franceschi F
    Heart Vessels; 2019 May; 34(5):824-831. PubMed ID: 30415372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.
    Le KY; Sohail MR; Friedman PA; Uslan DZ; Cha SS; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM;
    Heart Rhythm; 2011 Nov; 8(11):1678-85. PubMed ID: 21699855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac implantable electronic devices in adults with tetralogy of Fallot.
    Egbe AC; Miranda WR; Madhavan M; Ammash NM; Missula VR; Al-Otaibi M; Fatola A; Kothapalli S; Connolly HM
    Heart; 2019 Apr; 105(7):538-544. PubMed ID: 30377259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Characteristics and Outcome of Cardiovascular Implantable Electronic Device Infections in Turkey.
    Aydin M; Yildiz A; Kaya Z; Kaya Z; Basarir AO; Cakmak N; Donmez I; Morrad B; Avci A; Demir K; Cagliyan EC; Yuksel M; Elbey MA; Kayan F; Ozaydogdu N; Islamoglu Y; Cayli M; Alan S; Ulgen MS; Ozhan H
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):459-64. PubMed ID: 25589093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality and cost associated with cardiovascular implantable electronic device infections.
    Sohail MR; Henrikson CA; Braid-Forbes MJ; Forbes KF; Lerner DJ
    Arch Intern Med; 2011 Nov; 171(20):1821-8. PubMed ID: 21911623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study.
    Wu PJ; Chen HC; Fang YN; Chong SZ; Chen YL; Chen MC
    BMC Infect Dis; 2023 Nov; 23(1):787. PubMed ID: 37957553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices.
    Lin AY; Saul T; Aldaas OM; Lupercio F; Ho G; Pollema T; Pretorius V; Birgersdotter-Green U
    JACC Clin Electrophysiol; 2021 Jun; 7(6):755-763. PubMed ID: 33358664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.